IDEAYA Biosciences
(NASDAQ) IDYA
IDEAYA Biosciences Financials at a Glance
Market Cap
$3.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$225.27M
Net Income (TTM)
-$140.06M
EPS (TTM)
-$1.60
P/E Ratio
-23.57
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$39.48
Volume
61,601
Open
$38.00
Price
$39.48
Volume
61,601
Open
$38.00
Previous Close
$39.48
Daily Range
$37.76 - $39.50
52-Week Range
$20.99 - $39.51
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$39.48
Volume
61,601
Open
$38.00
Previous Close
$39.48
Daily Range
$37.76 - $39.50
52-Week Range
$20.99 - $39.51
Estimated Earnings Date
Aug 4, 2026
IDYA News
IDYA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout IDEAYA Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
145
CEO
Yujiro S. Hata, MBA
Website
www.ideayabio.comHeadquarters
South San Francisco, CA 94080, US
IDYA Financials
Key Financial Metrics (TTM)
Gross Margin
29.70%
Operating Margin
-81.44%
Net Income Margin
-62.17%
Return on Equity
-13.96%
Return on Capital
-15.16%
Return on Assets
-13.59%
Earnings Yield
-4.24%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
95.08M
Volume
61.60K
Avg. Volume
1.38M
Financials (TTM)
Gross Profit
$66.91M
Operating Income
-$183.47M
EBITDA
-$135.46M
Operating Cash Flow
-$85.93M
Capital Expenditure
-$2.01M
Free Cash Flow
-$87.93M
Cash & ST Invst.
$671.20M
Total Debt
$28.60M
IDEAYA Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.56M
N/A
Gross Profit
$5.42M
+107.6%
Gross Margin
82.58%
N/A
Market Cap
$3.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$27.33M
N/A
Employees
131
N/A
Net Income
-$98.54M
-38.0%
EBITDA
-$97.40M
-38.6%
Quarterly Fundamentals
Total Cash
$671.20M
-3.1%
Total Debt
$28.60M
+10.1%
Accounts Receivable
$6.56M
N/A
Inventory
$0.00
N/A
Long Term Debt
$28.25M
+10.1%
Short Term Debt
$350.00K
+13.6%
Return on Assets
-13.59%
N/A
Return on Invested Capital
-19.00%
N/A
Free Cash Flow
-$76.14M
-23.5%
Operating Cash Flow
-$75.17M
-24.6%